Eiko Lifescience

{
  "main_header": {
    "sid": 1002696,
    "name": "Eiko Lifescience",
    "stock_name": "Eiko Lifescience",
    "full_name": "Eiko Lifesciences Ltd",
    "name_url": "stocks-analysis/eiko-lifescience",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "49.16",
    "chg": 0.5,
    "chgp": "1.03%",
    "dir": 1,
    "prev_price": "48.66",
    "mcapval": "69.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540204,
    "symbol": "",
    "ind_name": "Specialty Chemicals",
    "ind_code": 5,
    "sector_id": 74,
    "indexname": "India SENSEX",
    "isin": "INE666Q01016",
    "curr_date": "Aug 10, 03:30 PM",
    "curr_time": "06:12 AM",
    "last_traded_at": "Aug 10, 03:30 PM IST",
    "bse_nse_vol": "8.86 k",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/eiko-lifescience-1002696-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-by-marketsmojo-4131274",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/EikoLifescience_mojoScore_4131274.png",
        "date": "2026-08-01 10:10:04",
        "description": "Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-by-marketsmojo-4131286",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/EikoLifescience_mojoScore_4131286.png",
        "date": "2026-08-01 10:10:04",
        "description": "Eiko Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 August 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-4112512",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/EikoLifescience_mojoScore_4112512.png",
        "date": "2026-07-21 10:10:04",
        "description": "Eiko Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-4095152",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/EikoLifescience_mojoScore_4095152.png",
        "date": "2026-07-09 10:10:05",
        "description": "Eiko Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 15 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 09 July 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-4075961",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/EikoLifescience_mojoScore_4075961.png",
        "date": "2026-06-28 10:10:06",
        "description": "Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 June 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-4058953",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/EikoLifescience_mojoScore_4058953.png",
        "date": "2026-06-17 10:10:03",
        "description": "Eiko Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and technical outlook."
      },
      {
        "title": "Are Eiko Lifesciences Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-eiko-lifesciences-ltd-latest-results-good-or-bad-4017433",
        "imagepath": "",
        "date": "2026-05-27 20:24:02",
        "description": "Eiko Lifesciences Ltd's latest financial results for Q4 FY26 present a complex picture characterized by significant topline growth alongside notable margin pressures. The company reported net sales of ₹18.34 crores, reflecting a robust year-on-year growth of 62.73% and a sequential increase of 53.09%. This performance marks the highest quarterly revenue in the company's history, indicating strong demand in its speciality chemicals segment.\n\nHowever, the operational metrics reveal challenges in profitability. The net profit for the quarter stood at ₹1.30 crores, which is a 23.81% increase year-on-year and a 7.44% rise quarter-on-quarter. Despite this profit growth, the operating margin (excluding other income) contracted to 12.43%, down from 15.69% in the previous quarter, raising concerns about the sustainability of this growth. The decline in margins suggests potential issues with pricing power or increase..."
      },
      {
        "title": "Eiko Lifesciences Q4 FY26: Strong Revenue Surge Masks Profitability Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/eiko-lifesciences-q4-fy26-strong-revenue-surge-masks-profitability-concerns-4015023",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EikoLifescience_quaterlyResult_4015023.png",
        "date": "2026-05-26 21:05:33",
        "description": "Eiko Lifesciences Ltd., a speciality chemicals manufacturer, reported a consolidated net profit of ₹1.30 crores for Q4 FY26, marking a modest sequential increase of 7.44% from ₹1.21 crores in Q3 FY26, though significantly ahead of the ₹1.05 crores posted in Q4 FY25—a year-on-year gain of 23.81%. The micro-cap company, with a market capitalisation of ₹73.00 crores, saw its stock surge 7.39% on May 26 to close at ₹53.03, as investors responded positively to the topline momentum despite lingering concerns about profitability metrics and weak return ratios."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-4013540",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EikoLifescience_mojoScore_4013540.png",
        "date": "2026-05-26 10:10:03",
        "description": "Eiko Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 20 Jan 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 26 May 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      }
    ],
    "total": 495,
    "sid": "1002696",
    "stock_news_url": "https://www.marketsmojo.com/news/eiko-lifesciences-1002696"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Meeting Scheduled To Be Held On 12Th August 2026",
      "datetime": "07-Aug-2026",
      "details": "Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve The Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended on 30th June 2026 in accordance with Regulation 33 of the SEBI Listing Regulation",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "13-Jul-2026",
      "details": "Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30th June 2026",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "24-Jun-2026",
      "details": "Trading Window shall remain closed for designated persons and their immediate relatives from Wednesday 01st July 2026 till 48 hours after the date of Board Meeting wherein inter-alia the approval of Un-Audited Standalone and Consolidated Financial Results for the quarter ended 30th June 2026 would be considered by the Board.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "12 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Eiko Lifesciences Ltd has declared <strong>2%</strong> dividend, ex-date: 20 Sep 17",
          "dt": "2017-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Eiko Lifesciences Ltd has announced <strong>2:3</strong> rights issue, ex-date: 07 Jul 23",
          "dt": "2023-07-07",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO

2026-08-01 10:10:04

Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO

2026-08-01 10:10:04

Eiko Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 August 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Eiko Lifesciences Ltd is Rated Sell

2026-07-21 10:10:04

Eiko Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Eiko Lifesciences Ltd is Rated Sell

2026-07-09 10:10:05

Eiko Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 15 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 09 July 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Eiko Lifesciences Ltd is Rated Sell

2026-06-28 10:10:06

Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 June 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Eiko Lifesciences Ltd is Rated Sell

2026-06-17 10:10:03

Eiko Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and technical outlook.

Read full news article

Are Eiko Lifesciences Ltd latest results good or bad?

2026-05-27 20:24:02

Eiko Lifesciences Ltd's latest financial results for Q4 FY26 present a complex picture characterized by significant topline growth alongside notable margin pressures. The company reported net sales of ₹18.34 crores, reflecting a robust year-on-year growth of 62.73% and a sequential increase of 53.09%. This performance marks the highest quarterly revenue in the company's history, indicating strong demand in its speciality chemicals segment. However, the operational metrics reveal challenges in profitability. The net profit for the quarter stood at ₹1.30 crores, which is a 23.81% increase year-on-year and a 7.44% rise quarter-on-quarter. Despite this profit growth, the operating margin (excluding other income) contracted to 12.43%, down from 15.69% in the previous quarter, raising concerns about the sustainability of this growth. The decline in margins suggests potential issues with pricing power or increase...

Read full news article

Eiko Lifesciences Q4 FY26: Strong Revenue Surge Masks Profitability Concerns

2026-05-26 21:05:33

Eiko Lifesciences Ltd., a speciality chemicals manufacturer, reported a consolidated net profit of ₹1.30 crores for Q4 FY26, marking a modest sequential increase of 7.44% from ₹1.21 crores in Q3 FY26, though significantly ahead of the ₹1.05 crores posted in Q4 FY25—a year-on-year gain of 23.81%. The micro-cap company, with a market capitalisation of ₹73.00 crores, saw its stock surge 7.39% on May 26 to close at ₹53.03, as investors responded positively to the topline momentum despite lingering concerns about profitability metrics and weak return ratios.

Read full news article

Eiko Lifesciences Ltd is Rated Sell

2026-05-26 10:10:03

Eiko Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 20 Jan 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 26 May 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

View All News